相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan A Retrospective Observational Study
Yingzhen Du et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection
Moussa Saleh et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin
Alberto Cipriani et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2020)
Optimizing the Trade-off Between Learning and Doing in a Pandemic
Derek C. Angus
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin
Ehud Chorin et al.
NATURE MEDICINE (2020)
Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19)
John R. Giudicessi et al.
MAYO CLINIC PROCEEDINGS (2020)
No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
J. M. Molina et al.
MEDECINE ET MALADIES INFECTIEUSES (2020)
Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance
[Anonymous]
PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE (2020)
Macrolides in critically ill patients with Middle East Respiratory Syndrome
Yaseen M. Arabi et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2019)
Estimated Cardiac Risk Associated With Macrolides and Fluoroquinolones Decreases Substantially When Adjusting for Patient Characteristics and Comorbidities
Linnea A. Polgreen et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Immunomodulatory indications of azithromycin in respiratory disease: a concise review for the clinician
Cassondra L. Cramer et al.
POSTGRADUATE MEDICINE (2017)
Use of azithromycin and risk of ventricular arrhythmia
Gianluca Trifiro et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2017)
Azithromycin Causes a Novel Proarrhythmic Syndrome
Zhenjiang Yang et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2017)
Macrolide antibiotics and the risk of ventricular arrhythmia in older adults
Mai H. Trac et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2016)
Co-Prescription of QT-Interval Prolonging Drugs: An Analysis in a Large Cohort of Geriatric Patients
Simone Schaechtele et al.
PLOS ONE (2016)
Zika virus cell tropism in the developing human brain and inhibition by azithromycin
Hanna Retallack et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Evaluation of Ebola Virus Inhibitors for Drug Repurposing
Peter B. Madrid et al.
ACS INFECTIOUS DISEASES (2015)
Risks of Cardiac Arrhythmia and Mortality Among Patients Using New-Generation Macrolides, Fluoroquinolones, and β-Lactam/β-Lactamase Inhibitors: A Taiwanese Nationwide Study
Hsu-Wen Chou et al.
CLINICAL INFECTIOUS DISEASES (2015)
Cardiovascular risks of antibiotics
Helene Vaillant-Roussel et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2014)
Association of Azithromycin With Mortality and Cardiovascular Events Among Older Patients Hospitalized With Pneumonia
Eric M. Mortensen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Efficacy of Combination Therapy with Oseltamivir Phosphate and Azithromycin for Influenza: A Multicenter, Open-Label, Randomized Study
Hiroshi Kakeya et al.
PLOS ONE (2014)
Azithromycin: Mechanisms of action and their relevance for clinical applications
Michael J. Parnham et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Azithromycin and Levofloxacin Use and Increased Risk of Cardiac Arrhythmia and Death
Gowtham A. Rao et al.
ANNALS OF FAMILY MEDICINE (2014)
Use of Azithromycin and Death from Cardiovascular Causes
Henrik Svanstrom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Azithromycin and the Risk of Cardiovascular Death
Charles A. Knirsch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Azithromycin and the Risk of Cardiovascular Death
Wayne A. Ray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications
Soichiro Kanoh et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
Antimicrobials and the Risk of Torsades de Pointes The Contribution from Data Mining of the US FDA Adverse Event Reporting System
Elisabetta Poluzzi et al.
DRUG SAFETY (2010)
Azithromycin induces anti-viral responses in bronchial epithelial cells
V. Gielen et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Azithromycin-induced torsade de pointes
Bien-Hsien Huang et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2007)
Azithromycin/Chloroquine combination does not increase cardiac instability despite an increase in monophasic action potential duration in the anesthetized guinea pig
Anthony A. Fossa et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2007)
Azithromycin for the secondary prevention of coronary artery disease: A meta-analysis
William L. Baker et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2007)
Azithromycin as a cause of QT-interval prolongation and torsade de pointes in the absence of other known precipitating factors
Anna Kezerashvili et al.
JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY (2007)
No proarrhythmic properties of the antibiotics moxifloxacin or azithromycin in anaesthetized dogs with chronic-AV block
M. B. Thomsen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
SARS: Systematic review of treatment effects
Lauren J. Stockman et al.
PLOS MEDICINE (2006)
Azithromycin for the secondary prevention of coronary events
JT Grayston et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: Fast phase 3 repolarization prevents early afterdepolarizations and Torsade de Pointes
P Milberg et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
QT prolongation associated with azithromycin/amiodarone combination
P Samarendra et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2001)
Risk of torsades de pointes from oral erythromycin with concomitant carbimazole (methimazole) administration
TW Koh
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2001)
Torsade de piontes and cardiorespiratory arrest induced by azithromycin in a patient with congenital long QT syndrome
E Arellano-Rodrigo et al.
MEDICINA CLINICA (2001)
QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience
F De Ponti et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2000)
分享论文
